This inventor holds 25 USPTO granted patents and 23 published patent applications and 13 EPO patents, primarily in Cancer Treatment Compounds. Top assignees: Genentech, Inc., F. Hoffmann-La Roche Ag, Hoffmann-La Roche Inc.. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- South San Francisco, CA (US) (2011 - 2018)
- Burlingame, CA (US) (2013 - 2021)
- San Francisco, CA (US) (2019 - 2023)
Company Filing History:
25 out of 3,302 
2 out of 181 
2 out of 5,027 
Years Active: 2011-2025
Areas of Expertise:
Title: Michael Siu: Innovating in Pharmaceutical Chemistry
Introduction
Michael Siu is a prominent inventor based in Burlingame, California, known for his significant contributions to pharmaceutical chemistry. With a remarkable portfolio of 21 patents, he has made strides in developing innovative compounds for treating various diseases.
Latest Patents
Among his latest patents are his work on 8-aminoisoquinoline compounds and their applications. These compounds serve as inhibitors of HPK1 (hematopoietic kinase 1) and are essential in treating HPK1-dependent disorders, while also enhancing immune responses. His research includes methods for inhibiting HPK1, treating related disorders, enhancing immune function, and preparing carbonylamino-8-aminoisoquinoline compounds. Additionally, he has developed biheteroaryl compounds aimed at addressing neurodegenerative diseases, expanding the potential therapeutic approaches for patients.
Career Highlights
Michael Siu has built an impressive career in the pharmaceutical field, working with leading companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. His collaborations and innovations within these organizations have contributed to advancements in drug discovery and development.
Collaborations
During his time in the industry, Michael has worked alongside talented professionals, including Snahel Patel and Alan G. Olivero. These collaborations have fostered a creative environment for innovation, paving the way for breakthrough developments in medicine.
Conclusion
Michael Siu's impressive record of patents and collaborations signifies his dedication to improving healthcare through innovative science. His research not only opens new pathways for treatment but also enhances our understanding of the underlying mechanisms of various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile